Literature DB >> 30682353

Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.

Hongdou Ding1, Haifeng Wang1, Li Xu1, Nan Song1, Gening Jiang2.   

Abstract

BACKGROUND: We investigated the association between survival and the number of examined lymph nodes after sublobar resection for node-negative non-small cell lung cancer with size of 2 cm or less.
METHODS: The Surveillance, Epidemiology, and End Results database was used to identify patients diagnosed with non-small cell lung cancer 2 cm or less from 2004 to 2014 and underwent wedge resection or segmentectomy. Patients were stratified by the procedure (wedge resection, segmentectomy), the size of tumors (≤1 cm, 1 to 2 cm), and the number of lymph nodes examined (0, 1 to 3, 4 to 9, ≥10). The relationship between the number of resected lymph nodes and overall survival (OS)/lung cancer-specific survival (LCSS) was analyzed.
RESULTS: A total of 2,298 patients with wedge resection and 566 patients with segmentectomy were identified. Segmentectomy was performed for bigger tumors (1.43 cm versus 1.38 cm) and was associated with more lymph nodes resected (median number: 3 versus 1). Multivariable analysis after propensity score matching revealed that lymph node resection improved survival for patients undergoing wedge resection while not for patients undergoing segmentectomy. In the wedge resection group, 1 to 3 nodes resected improved OS and 4 to 9 nodes improved OS and LCSS compared with patients without nodes evaluated for lesions 1 cm or less. No survival benefit was observed when 10 or more nodes were resected. For lesions 1 to 2 cm, incremental improvement in survival appeared with the increase of examined lymph node number. More than 16 nodes resected conferred no additional survival benefit compared with patients with 10 to 16 nodes resected.
CONCLUSIONS: In wedge resection, 4 to 9 and 10 to 16 lymph nodes should be examined for lesions 1 cm or less and 1 to 2 cm, respectively. In segmentectomy, lymph node resection did not confer survival benefits for lesions 2 cm or less.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30682353     DOI: 10.1016/j.athoracsur.2018.12.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy.

Authors:  Shoujie Feng; Xiangming Liu; Bing Huang; Jing Shi; Hao Zhang
Journal:  Front Surg       Date:  2022-06-09

2.  Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer.

Authors:  Gaoxiang Wang; Xianning Wu; Xiaohui Sun; Tian Li; Meiqing Xu; Liangdong Xu; Mingran Xie
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

3.  Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.

Authors:  Lei-Lei Wu; Jia-Jian Lai; Xuan Liu; Yang-Yu Huang; Peng Lin; Hao Long; Lan-Jun Zhang; Guo-Wei Ma
Journal:  World J Surg Oncol       Date:  2020-12-07       Impact factor: 2.754

4.  The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study.

Authors:  Wenyu Zhai; Yuzhen Zheng; Yuming Rong; Xiaoqiang Li; Qihang Yan; Fangfang Duan; Zerui Zhao; Jianlong Chen; Shuqin Dai; Junye Wang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

5.  Individualized dorsal basal segment (S10) resection using intersegmental veins as the landmark.

Authors:  Zhicheng He; Xianglong Pan; Zhihua Li; Qi Wang; Jun Wang; Wei Wen; Quan Zhu; Weibing Wu; Liang Chen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

6.  Exploration of the optimal number of regional lymph nodes removed for resected N0 NSCLC patients: A population-based study.

Authors:  Anjie Yao; Zixuan Liu; Hanyu Rao; Yilun Shen; Changhui Wang; Shuanshuan Xie
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

7.  Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study.

Authors:  Dan Tian; Xiaosong Ben; Sichao Wang; Weitao Zhuang; Jiming Tang; Liang Xie; Haiyu Zhou; Dongkun Zhang; Zihao Zhou; Ruiqing Shi; Cheng Deng; Yu Ding; Xuanye Zhang; Guibin Qiao
Journal:  Ann Transl Med       Date:  2021-05

8.  Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer ≤1 or >1 to 2 cm.

Authors:  Enkuo Zheng; Minglei Yang; Rui Li; Junjun Ni; Xiang Xu; Guofang Zhao
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.